Anna Maria Barbui

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

Alfredo Marzano, Mauro Salizzoni, W. Debernardi‐Venon et al. · Journal of Hepatology · 2001 · 224 citations

Transplantation, Hepatology, Cirrhotic Patients +10

Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma

Corrado Tarella, Roberto Passera, Michele Magni et al. · Journal of Clinical Oncology · 2010 · 166 citations · Full text

Genetic Modification of Human T Cells with CD20: A Strategy to Purify and Lyse Transduced Cells with Anti-CD20 Antibodies

Martino Introna, Anna Maria Barbui, Federica Bambacioni et al. · Human Gene Therapy · 2000 · 143 citations

Adaptive Immune System, T-regulatory Cell, Lyse Transduced Cells +18

High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma.

Fabrizio Marcucci, Alfonso Mele, Enea Spada et al. · PubMed · 2006 · 138 citations

Immunology, Hepatitis B, Pathology +16

Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin

Bruna Lavezzo, A Franchello, A. Smedile et al. · Journal of Hepatology · 2002 · 120 citations

Hepatology, Hepatitis C, Viral Hepatitis +8